文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性相关遗传变异效应随年龄变化

The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

国际AMD基因组联盟纳入27996人(晚发AMD 14539例,对照13457例),按60-69、70-79、80-89及≥90岁分组,评估51个晚发AMD相关遗传变异的效应。发现6个变异在≥90岁人群中与晚发AMD相关,CFH和ARMS2变异效应随年龄降低,≥90岁者总遗传风险低于70-79岁者。

要点

  • ≥90岁人群中6个遗传变异与晚发AMD相关(P≤0.0006)。
  • CFH和ARMS2变异在更大年龄时效应量更低。
  • ≥90岁者总遗传风险低于70-79岁者(AUC 0.795 vs 0.831,P=0.03)。

核心结论

  • 晚发AMD遗传风险因素的效应量和MAF在不同年龄组间存在差异。
  • CFH和ARMS2变异在更大年龄时效应量更低,总遗传风险在≥90岁人群中较低。

研究设计与样本

  • 国际AMD基因组联盟的协作研究,纳入27996人,其中晚发AMD 14539例(51.9%),对照13457例(48.1%)。
  • 按年龄分为60-69岁(n=6514,AMD=2210)、70-79岁(n=12228,AMD=6217)、80-89岁(n=8285,AMD=5326)和≥90岁(n=969,AMD=686)四组。
  • 计算51个AMD相关遗传变异在各年龄组的效应量并进行组间比较。

主要发现

  • 6个变异在≥90岁人群中与晚发AMD相关(P≤0.0006)。
  • rs10922109和rs570618(均位于CFH)的次要等位基因具有保护性,病例和对照中MAF随年龄增加。
  • rs116503776(位于C2/CFB/SKIV2L)的次要等位基因具有保护性,病例中MAF增加。
  • rs3750846(位于ARMS2/HTRA1)的次要等位基因增加风险,病例中MAF随年龄增加而降低;rs6565597(位于NPLOC4/TSPAN10)的次要等位基因增加风险;rs5754227(位于SYN3/TIMP3)的次要等位基因具有保护性,MAF随年龄无一致变化。
  • CFH和ARMS2变异在更大年龄时效应量更低;交互分析显示rs570618(P=2.24×10-7)和rs3750846(P=0.001)存在强年龄相关效应。

关键数值与推荐

  • ≥90岁人群总遗传风险的AUC为0.795,低于70-79岁人群的0.831(P=0.03)。

临床怎么用

  • 提示在老年人群中进行AMD遗传风险评估时需考虑年龄对遗传变异效应的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prevalence of age-related macular degeneration (AMD) increases dramatically with age. This large collaborative study investigates the effects of 51 late-AMD-associated genetic variants in different ages, focusing on individuals above the age of 90 years. METHODS: The study included 27,996 individuals of the International AMD Genomics Consortium; 14,539 showed late AMD (51.9%) and 13,457 were controls (48.1%). Four age groups were compiled: 60 to 69 years, n = 6514, AMD = 2210 (33.9%); 70 to 79 years, n = 12228, AMD = 6217 (51.7%); 80 to 89 years, n = 8285, AMD = 5326 (64.3%); and ≥90 years, n = 969, AMD = 686 (70.8%). The effect sizes of 51 AMD-associated genetic variants were calculated for all age groups and were compared among the age groups. RESULTS: Six variants were associated with late AMD in individuals ≥ 90 years of age (P ≤ 0.0006). For rs10922109 and rs570618 (both in CFH), the minor allele (MA) was protective, and minor allele frequency (MAF) increased with age in cases and controls. For rs116503776 in C2/CFB/SKIV2L, the MA was protective, and MAF increased in cases. For rs3750846 in ARMS2/HTRA1, the MA increased risk, and MAF was lower in cases with increasing age. For rs6565597 in NPLOC4/TSPAN10, the MA increased risk. For rs5754227 in SYN3/TIMP3, the MA was protective, and there was no consistent variation in MAF with age. Variants in CFH and ARMS2 showed lower effect sizes at greater age. Interaction analysis showed strong age-related effects for rs570618 (P = 2.24 × 10-7) and rs3750846 (P = 0.001). Total genetic risk was lower in individuals ≥ 90 years old (area under the curve [AUC], 0.795) than in those 70 to 79 years old (AUC, 0.831; P = 0.03). CONCLUSIONS: Effect sizes and MAF of genetic risk factors for late AMD differed among the age groups. These results could guide future work on AMD risk assessment in older individuals.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Schick T, Lorés-Motta L, Altay L, et al. The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age. Invest Ophthalmol Vis Sci. 2020. PMID: 33320170. doi:10.1167/iovs.61.14.17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。